1. Home
  2. SXC vs CTMX Comparison

SXC vs CTMX Comparison

Compare SXC & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunCoke Energy Inc.

SXC

SunCoke Energy Inc.

HOLD

Current Price

$9.69

Market Cap

801.2M

Sector

Industrials

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$3.28

Market Cap

716.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SXC
CTMX
Founded
1960
2008
Country
United States
United States
Employees
848
69
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
801.2M
716.9M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
SXC
CTMX
Price
$9.69
$3.28
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$9.00
$12.10
AVG Volume (30 Days)
1.8M
2.2M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
7.17%
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$1,600,300,000.00
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.61
P/E Ratio
$94.00
$22.58
Revenue Growth
10.30
N/A
52 Week Low
$5.52
$1.90
52 Week High
$9.92
$8.21

Technical Indicators

Market Signals
Indicator
SXC
CTMX
Relative Strength Index (RSI) 59.07 47.01
Support Level $7.52 $3.01
Resistance Level $9.79 $3.55
Average True Range (ATR) 0.37 0.15
MACD 0.00 0.01
Stochastic Oscillator 83.12 31.17

Price Performance

Historical Comparison
SXC
CTMX

About SXC SunCoke Energy Inc.

SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: